- Home
- Equipment
- united kingdom
- vaccine designed
Refine by
Vaccine Designed Equipment Supplied In United Kingdom
5 equipment items found
Manufactured by:SureChill based inCardiff, UNITED KINGDOM
The GVR50 AC medical refrigerator, powered by the innovative SureChill technology, ensures precise temperature control with no risk of freezing, making it ideal for storing temperature-sensitive drugs and vaccines. Designed for energy efficiency, it operates on mains electric power at both 220V and 110V, with a holdover time exceeding 7 days and requiring only ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals and ethnicities. PolyPEPI-SCoV-2 vaccine can elicit broad and ...
Manufactured by:Oxford Vacmedix UK Limited based inOxford, UNITED KINGDOM
Tumours can often avoid being targeted by these T Cells by looking like a cell found normally in the body often referred to as “self”. If a group of T Cells can be encouraged to recognise these tumours as foreign and not self then they will attack the tumour and provide an effective treatment against it. Injecting a preparation that stimulates these T Cells effectively vaccinates the ...
Manufactured by:Polar Thermal Packaging Ltd based inWarminster, UNITED KINGDOM
The Vaccine – BluKoat Insulated Transport Bag is a cutting-edge solution designed for the secure and efficient transportation of vaccines. This product, designed by Polar Thermal Packaging, offers a sophisticated insulation system using patented Polar Thermal material with a thickness of 45mm to provide effective thermal ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
ImmunoBody vaccines are designed to generate potent T cell responses capable of a broad anti-tumour effect. They are DNA vaccines that encode a protein in the form of an antibody, but the parts of the antibody that would normally bind to the target protein are replaced with epitopes from a cancer ...